303 related articles for article (PubMed ID: 22406360)
21. NRAS and BRAF mutation frequency in primary oral mucosal melanoma.
Buery RR; Siar CH; Katase N; Gunduz M; Lefeuvre M; Fujii M; Inoue M; Setsu K; Nagatsuka H
Oncol Rep; 2011 Oct; 26(4):783-7. PubMed ID: 21750866
[TBL] [Abstract][Full Text] [Related]
22. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
[TBL] [Abstract][Full Text] [Related]
23. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
24. Superficial paramucosal clear cell sarcoma of the soft parts resembling melanoma in a 13-year-old boy.
Sidiropoulos M; Busam K; Guitart J; Laskin WB; Wagner AM; Gerami P
J Cutan Pathol; 2013 Feb; 40(2):265-8. PubMed ID: 23228147
[TBL] [Abstract][Full Text] [Related]
25. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).
Wang WL; Mayordomo E; Zhang W; Hernandez VS; Tuvin D; Garcia L; Lev DC; Lazar AJ; López-Terrada D
Mod Pathol; 2009 Sep; 22(9):1201-9. PubMed ID: 19561568
[TBL] [Abstract][Full Text] [Related]
26. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
27. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.
Rossi S; Szuhai K; Ijszenga M; Tanke HJ; Zanatta L; Sciot R; Fletcher CD; Dei Tos AP; Hogendoorn PC
Clin Cancer Res; 2007 Dec; 13(24):7322-8. PubMed ID: 18094413
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma.
Falconieri G; Bacchi CE; Luzar B
Am J Dermatopathol; 2012 Aug; 34(6):619-25. PubMed ID: 22421295
[TBL] [Abstract][Full Text] [Related]
29. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Tanami H; Imoto I; Hirasawa A; Yuki Y; Sonoda I; Inoue J; Yasui K; Misawa-Furihata A; Kawakami Y; Inazawa J
Oncogene; 2004 Nov; 23(54):8796-804. PubMed ID: 15467732
[TBL] [Abstract][Full Text] [Related]
30. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
Patel RM; Downs-Kelly E; Weiss SW; Folpe AL; Tubbs RR; Tuthill RJ; Goldblum JR; Skacel M
Mod Pathol; 2005 Dec; 18(12):1585-90. PubMed ID: 16258500
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.
Wagner BP; Epperla N; Medina-Flores R
Diagn Pathol; 2013 Nov; 8():192. PubMed ID: 24274261
[TBL] [Abstract][Full Text] [Related]
33. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Colombino M; Capone M; Lissia A; Cossu A; Rubino C; De Giorgi V; Massi D; Fonsatti E; Staibano S; Nappi O; Pagani E; Casula M; Manca A; Sini M; Franco R; Botti G; Caracò C; Mozzillo N; Ascierto PA; Palmieri G
J Clin Oncol; 2012 Jul; 30(20):2522-9. PubMed ID: 22614978
[TBL] [Abstract][Full Text] [Related]
34. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
[TBL] [Abstract][Full Text] [Related]
35. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.
Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ
Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680
[TBL] [Abstract][Full Text] [Related]
36. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
Capper D; Preusser M; Habel A; Sahm F; Ackermann U; Schindler G; Pusch S; Mechtersheimer G; Zentgraf H; von Deimling A
Acta Neuropathol; 2011 Jul; 122(1):11-9. PubMed ID: 21638088
[TBL] [Abstract][Full Text] [Related]
37. Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation.
Jakubauskas A; Valceckiene V; Andrekute K; Seinin D; Kanopka A; Griskevicius L
Exp Mol Pathol; 2011 Apr; 90(2):194-200. PubMed ID: 21185830
[TBL] [Abstract][Full Text] [Related]
38. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.
Lee JH; Choi JW; Kim YS
Br J Dermatol; 2011 Apr; 164(4):776-84. PubMed ID: 21166657
[TBL] [Abstract][Full Text] [Related]
39. Absence of BRAF and NRAS mutations in uveal melanoma.
Cruz F; Rubin BP; Wilson D; Town A; Schroeder A; Haley A; Bainbridge T; Heinrich MC; Corless CL
Cancer Res; 2003 Sep; 63(18):5761-6. PubMed ID: 14522897
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
Decarlo K; Yang S; Emley A; Wajapeyee N; Green M; Mahalingam M
Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
